title: The effect of pregnancy on survival in women with cystic fibrosis.
abstract: OBJECTIVE
  Patients with cystic fibrosis (CF) are currently living to their fourth decade and are making reproductive decisions. Information concerning the reproductive health of women with CF has been limited to small or single-center studies.
  
  
  METHODS
  We conducted a matched parallel-cohort study to assess the impact of pregnancy on the survival of women with CF.
  
  
  METHODS
  A parallel-cohort study included all women > 12 years of age who were enrolled in the US Cystic Fibrosis Foundation National Patient Registry from 1985 to 1997.
  
  
  RESULTS
  Six hundred eighty of the 8,136 women in the cohort became pregnant. These 680 women were matched on an index year to 3,327 control women with CF. At the inception of entry into the cohort, women who reported pregnancy were more likely to have had a higher percentage of predicted FEV(1) (67.5% predicted vs 61.7% predicted, respectively; p < 0.001) and a higher weight (52.9 vs 46.4 kg, respectively; p < 0.001). Using Kaplan-Meier survival curves, the 10-year survival rate in pregnant women (77%; 95% confidence interval [CI], 71 to 82%) was higher than in those women who did not become pregnant (58%; 95% CI, 55 to 62%). A separate analysis, matching pregnant patients on FEV(1) percent predicted, age, Pseudomonas aeruginosa colonization, and pancreatic function, obtained similar results. Using Cox proportional hazard modeling to adjust for baseline age, FEV(1) percent predicted, weight, height, and pulmonary exacerbation rate per year, pregnancy was not associated with an increase risk of death. Pregnancy was not harmful in any subgroup including patients with FEV(1) < 40% of predicted or diabetes mellitus.
  
  
  CONCLUSIONS
  Women with CF who became pregnant were initially healthier and had better 10-year survival rates than women with CF who did not become pregnant. After adjustment for the initial severity of illness, women who became pregnant did not have a significantly shortened survival.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington Medical Center, Seattle, WA 98195, USA. goss@u.washington.edu
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Goss
authors.forename: Gordon D
authors.initials: GD
authors.lastname: Rubenfeld
authors.forename: Kelly
authors.initials: K
authors.lastname: Otto
authors.forename: Moira L
authors.initials: ML
authors.lastname: Aitken
mesh_terms: D000328:Adult; D003550:Cystic Fibrosis / Q000401:mortality* / Q000503:physiopathology; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000401:mortality* / Q000503:physiopathology; D011446:Prospective Studies; D012042:Registries; D015996:Survival Rate